BIO’s new CEO takes a patriotic pivot to win back Congress, pushing industry to rethink China relationship

SAN DIEGO — Facing an existential moment in how drugs are developed and sold, biotech’s key lobbying group has entrusted a new leader, who is wrapping …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Opinion | What Can Primary Care Physicians Do for Our Aging Population?

Davidoff is a healthcare executive and board-certified urologist. People today are living longer than ever before, and the proportion of older adults in the population

September 7, 2023

Groundbreaking project seeks to illuminate the complexities of Parkinson’s

Launching today, Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The project brings together Parkinson’s UK, Imperial College

September 24, 2024

Neuroscience company Rapport Therapeutics lists on Nasdaq

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.